Get Real Time Here
| Open16.990 | Close17.140 |
| Vol / Avg.2.944K / 9.257K | Mkt Cap458.091M |
| Day Range16.950 - 17.190 | 52 Wk Range10.820 - 25.640 |
Calliditas Therapeutics Stock (NASDAQ:CALT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Calliditas Therapeutics (CALT)?
There have been no specific sales or earnings guidance reported for Calliditas Therapeutics in recent months.
Browse guidance and forecast on all stocks.
Calliditas Therapeutics Stock (NASDAQ:CALT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Calliditas Therapeutics (CALT)?
There have been no specific sales or earnings guidance reported for Calliditas Therapeutics in recent months.
Browse guidance and forecast on all stocks.
Calliditas Therapeutics Stock (NASDAQ:CALT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Calliditas Therapeutics (CALT)?
There have been no specific sales or earnings guidance reported for Calliditas Therapeutics in recent months.
Browse guidance and forecast on all stocks.
Calliditas Therapeutics Stock (NASDAQ:CALT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Calliditas Therapeutics (CALT)?
There have been no specific sales or earnings guidance reported for Calliditas Therapeutics in recent months.
Browse guidance and forecast on all stocks.
Calliditas Therapeutics Stock (NASDAQ:CALT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Calliditas Therapeutics (CALT)?
There have been no specific sales or earnings guidance reported for Calliditas Therapeutics in recent months.
Browse guidance and forecast on all stocks.
Calliditas Therapeutics Stock (NASDAQ:CALT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Calliditas Therapeutics (CALT)?
There have been no specific sales or earnings guidance reported for Calliditas Therapeutics in recent months.
Browse guidance and forecast on all stocks.
Calliditas Therapeutics Stock (NASDAQ:CALT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Calliditas Therapeutics (CALT)?
There have been no specific sales or earnings guidance reported for Calliditas Therapeutics in recent months.
Browse guidance and forecast on all stocks.
Calliditas Therapeutics Stock (NASDAQ:CALT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Calliditas Therapeutics (CALT)?
There have been no specific sales or earnings guidance reported for Calliditas Therapeutics in recent months.
Browse guidance and forecast on all stocks.
Calliditas Therapeutics Stock (NASDAQ:CALT), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
What is the most recent guidance for Calliditas Therapeutics (CALT)?
There have been no specific sales or earnings guidance reported for Calliditas Therapeutics in recent months.
Browse guidance and forecast on all stocks.